Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Vaisband

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Investigative Ophthalmology & Visual Science|February 26, 2026
Near-Infrared Fluorescence Lifetime Imaging Microscopy Reveals Loss of RPE Cell Body Polarity in Age-Related Macular DegenerationKatharina Wall, Sebastian Fritsch, Marc Vaisband, et al.
Investigative Ophthalmology & Visual Science|January 3, 2024
Spectral Analysis of Human Retinal Pigment Epithelium Cells in Healthy and AMD EyesLeonie Bourauel, Marc Vaisband, Leon von der Emde, et al.
Translational Vision Science & Technology|August 19, 2022
Histologic Cell Shape Descriptors for the Retinal Pigment Epithelium in Age-Related Macular Degeneration: A Comparison to Unaffected EyesLeon von der Emde, Marc Vaisband, Jan Hasenauer, et al.
Scientific Reports|October 13, 2023
Retest variability and patient reliability indices of quantitative fundus autofluorescence in age-related macular degeneration: a MACUSTAR study reportLeon von der Emde, Merten Mallwitz, Marc Vaisband, et al.
Cancers|March 11, 2023
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMTLisa Pleyer, Sonja Heibl, Christoph Tinchon, et al.
American Journal of Hematology|August 7, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMTLisa Pleyer, Marc Vaisband, Manuel Drost, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Investigative Ophthalmology & Visual Science|February 26, 2026
Near-Infrared Fluorescence Lifetime Imaging Microscopy Reveals Loss of RPE Cell Body Polarity in Age-Related Macular DegenerationKatharina Wall, Sebastian Fritsch, Marc Vaisband, et al.
Investigative Ophthalmology & Visual Science|January 3, 2024
Spectral Analysis of Human Retinal Pigment Epithelium Cells in Healthy and AMD EyesLeonie Bourauel, Marc Vaisband, Leon von der Emde, et al.
Translational Vision Science & Technology|August 19, 2022
Histologic Cell Shape Descriptors for the Retinal Pigment Epithelium in Age-Related Macular Degeneration: A Comparison to Unaffected EyesLeon von der Emde, Marc Vaisband, Jan Hasenauer, et al.
Scientific Reports|October 13, 2023
Retest variability and patient reliability indices of quantitative fundus autofluorescence in age-related macular degeneration: a MACUSTAR study reportLeon von der Emde, Merten Mallwitz, Marc Vaisband, et al.
Cancers|March 11, 2023
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMTLisa Pleyer, Sonja Heibl, Christoph Tinchon, et al.
American Journal of Hematology|August 7, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMTLisa Pleyer, Marc Vaisband, Manuel Drost, et al.
Pageof 2